BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Contestabile A, Magara S, Cancedda L. The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome. Front Cell Neurosci 2017;11:54. [PMID: 28326014 DOI: 10.3389/fncel.2017.00054] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 10.6] [Reference Citation Analysis]
Number Citing Articles
1 Lanzillotta C, Zuliani I, Tramutola A, Barone E, Blarzino C, Folgiero V, Caforio M, Valentini D, Villani A, Locatelli F, Butterfield DA, Head E, Perluigi M, Abisambra JF, Di Domenico F. Chronic PERK induction promotes Alzheimer-like neuropathology in Down syndrome: Insights for therapeutic intervention. Prog Neurobiol 2021;196:101892. [PMID: 32795489 DOI: 10.1016/j.pneurobio.2020.101892] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Foliaki ST, Schwarz B, Groveman BR, Walters RO, Ferreira NC, Orrù CD, Smith A, Wood A, Schmit OM, Freitag P, Yuan J, Zou W, Bosio CM, Carroll JA, Haigh CL. Neuronal excitatory-to-inhibitory balance is altered in cerebral organoid models of genetic neurological diseases. Mol Brain 2021;14:156. [PMID: 34635127 DOI: 10.1186/s13041-021-00864-w] [Reference Citation Analysis]
3 Chen W, Cai ZL, Chao ES, Chen H, Longley CM, Hao S, Chao HT, Kim JH, Messier JE, Zoghbi HY, Tang J, Swann JW, Xue M. Stxbp1/Munc18-1 haploinsufficiency impairs inhibition and mediates key neurological features of STXBP1 encephalopathy. Elife 2020;9:e48705. [PMID: 32073399 DOI: 10.7554/eLife.48705] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
4 Gupta P, Makkar TK, Goel L, Pahuja M. Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity. Immunol Res 2022. [PMID: 35859244 DOI: 10.1007/s12026-022-09307-7] [Reference Citation Analysis]
5 Valbuena S, García Á, Mazier W, Paternain AV, Lerma J. Unbalanced dendritic inhibition of CA1 neurons drives spatial-memory deficits in the Ts2Cje Down syndrome model. Nat Commun 2019;10:4991. [PMID: 31676751 DOI: 10.1038/s41467-019-13004-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
6 Di Domenico F, Tramutola A, Barone E, Lanzillotta C, Defever O, Arena A, Zuliani I, Foppoli C, Iavarone F, Vincenzoni F, Castagnola M, Butterfield DA, Perluigi M. Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome. Redox Biol 2019;23:101162. [PMID: 30876754 DOI: 10.1016/j.redox.2019.101162] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
7 Best KM, Asaro LA, Curley MAQ; Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) Study Investigators. Sedation Management for Critically Ill Children with Pre-Existing Cognitive Impairment. J Pediatr 2019;206:204-211.e1. [PMID: 30527750 DOI: 10.1016/j.jpeds.2018.10.042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
8 Savardi A, Borgogno M, Narducci R, La Sala G, Ortega JA, Summa M, Armirotti A, Bertorelli R, Contestabile A, De Vivo M, Cancedda L. Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders. Chem 2020;6:2073-96. [PMID: 32818158 DOI: 10.1016/j.chempr.2020.06.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
9 Rujeedawa T, Carrillo Félez E, Clare ICH, Fortea J, Strydom A, Rebillat AS, Coppus A, Levin J, Zaman SH. The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer's Disease. J Clin Med 2021;10:4582. [PMID: 34640600 DOI: 10.3390/jcm10194582] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Rishitha N, Muthuraman A. Therapeutic evaluation of solid lipid nanoparticle of quercetin in pentylenetetrazole induced cognitive impairment of zebrafish. Life Sciences 2018;199:80-7. [DOI: 10.1016/j.lfs.2018.03.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
11 Moreno DG, Utagawa EC, Arva NC, Schafernak KT, Mufson EJ, Perez SE. Postnatal Cytoarchitecture and Neurochemical Hippocampal Dysfunction in Down Syndrome. J Clin Med 2021;10:3414. [PMID: 34362198 DOI: 10.3390/jcm10153414] [Reference Citation Analysis]
12 Palmer CR, Liu CS, Romanow WJ, Lee MH, Chun J. Altered cell and RNA isoform diversity in aging Down syndrome brains. Proc Natl Acad Sci U S A 2021;118:e2114326118. [PMID: 34795060 DOI: 10.1073/pnas.2114326118] [Reference Citation Analysis]
13 Mohamad FH, Has ATC. The α5-Containing GABAA Receptors-a Brief Summary. J Mol Neurosci 2019;67:343-51. [PMID: 30607899 DOI: 10.1007/s12031-018-1246-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
14 Hamburg S, Bush D, Strydom A, Startin CM. Comparison of resting-state EEG between adults with Down syndrome and typically developing controls. J Neurodev Disord 2021;13:48. [PMID: 34649497 DOI: 10.1186/s11689-021-09392-z] [Reference Citation Analysis]
15 Uguagliati B, Al-Absi AR, Stagni F, Emili M, Giacomini A, Guidi S, Nyengaard JR, Bartesaghi R. Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome. Hippocampus 2021;31:435-47. [PMID: 33464704 DOI: 10.1002/hipo.23303] [Reference Citation Analysis]
16 Franceschi C, Garagnani P, Gensous N, Bacalini MG, Conte M, Salvioli S. Accelerated bio-cognitive aging in Down syndrome: State of the art and possible deceleration strategies. Aging Cell 2019;18:e12903. [PMID: 30768754 DOI: 10.1111/acel.12903] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
17 Pozzi D, Rasile M, Corradini I, Matteoli M. Environmental regulation of the chloride transporter KCC2: switching inflammation off to switch the GABA on? Transl Psychiatry 2020;10:349. [PMID: 33060559 DOI: 10.1038/s41398-020-01027-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
18 Mazzarino RC, Baresova V, Zikánová M, Duval N, Wilkinson TG 2nd, Patterson D, Vacano GN. Transcriptome and metabolome analysis of crGART, a novel cell model of de novo purine synthesis deficiency: Alterations in CD36 expression and activity. PLoS One 2021;16:e0247227. [PMID: 34283828 DOI: 10.1371/journal.pone.0247227] [Reference Citation Analysis]
19 Jeong N, Singer AC. Learning from inhibition: Functional roles of hippocampal CA1 inhibition in spatial learning and memory. Curr Opin Neurobiol 2022;76:102604. [PMID: 35810533 DOI: 10.1016/j.conb.2022.102604] [Reference Citation Analysis]
20 Vacca RA, Bawari S, Valenti D, Tewari D, Nabavi SF, Shirooie S, Sah AN, Volpicella M, Braidy N, Nabavi SM. Down syndrome: Neurobiological alterations and therapeutic targets. Neuroscience & Biobehavioral Reviews 2019;98:234-55. [DOI: 10.1016/j.neubiorev.2019.01.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
21 Ponroy Bally B, Murai KK. Astrocytes in Down Syndrome Across the Lifespan. Front Cell Neurosci 2021;15:702685. [PMID: 34483840 DOI: 10.3389/fncel.2021.702685] [Reference Citation Analysis]
22 Flood L, Korol SV, Ekselius L, Birnir B, Jin Z. Interferon-γ potentiates GABAA receptor-mediated inhibitory currents in rat hippocampal CA1 pyramidal neurons. J Neuroimmunol 2019;337:577050. [PMID: 31505410 DOI: 10.1016/j.jneuroim.2019.577050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Baburamani AA, Patkee PA, Arichi T, Rutherford MA. New approaches to studying early brain development in Down syndrome. Dev Med Child Neurol 2019;61:867-79. [PMID: 31102269 DOI: 10.1111/dmcn.14260] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
24 Hamburg S, Rosch R, Startin CM, Friston KJ, Strydom A. Dynamic Causal Modeling of the Relationship between Cognition and Theta-alpha Oscillations in Adults with Down Syndrome. Cereb Cortex 2019;29:2279-90. [PMID: 30877793 DOI: 10.1093/cercor/bhz043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
25 Joshi K, Shen L, Cao F, Dong S, Jia Z, Cortez MA, Snead OC 3rd. Kcnj6(GIRK2) trisomy is not sufficient for conferring the susceptibility to infantile spasms seen in the Ts65Dn mouse model of down syndrome. Epilepsy Res 2018;145:82-8. [PMID: 29929098 DOI: 10.1016/j.eplepsyres.2018.06.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kipnis PA, Kadam SD. Novel Concepts for the Role of Chloride Cotransporters in Refractory Seizures. Aging Dis 2021;12:1056-69. [PMID: 34221549 DOI: 10.14336/AD.2021.0129] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sullivan KD, Evans D, Pandey A, Hraha TH, Smith KP, Markham N, Rachubinski AL, Wolter-Warmerdam K, Hickey F, Espinosa JM, Blumenthal T. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. Sci Rep 2017;7:14818. [PMID: 29093484 DOI: 10.1038/s41598-017-13858-3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 15.6] [Reference Citation Analysis]
28 Lowe SA, Hodge JJL, Usowicz MM. A third copy of the Down syndrome cell adhesion molecule (Dscam) causes synaptic and locomotor dysfunction in Drosophila. Neurobiol Dis 2018;110:93-101. [PMID: 29196216 DOI: 10.1016/j.nbd.2017.11.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
29 Fonseca LM, Mattar GP, Haddad GG, Burduli E, McPherson SM, Guilhoto LMFF, Yassuda MS, Busatto GF, Bottino CMC, Hoexter MQ, Chaytor NS. Neuropsychiatric Symptoms of Alzheimer's Disease in Down Syndrome and Its Impact on Caregiver Distress. J Alzheimers Dis 2021;81:137-54. [PMID: 33749644 DOI: 10.3233/JAD-201009] [Reference Citation Analysis]
30 van Rhijn JR, Fisher SE, Vernes SC, Nadif Kasri N. Foxp2 loss of function increases striatal direct pathway inhibition via increased GABA release. Brain Struct Funct 2018;223:4211-26. [PMID: 30187194 DOI: 10.1007/s00429-018-1746-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
31 Duba-Kiss R, Niibori Y, Hampson DR. GABAergic Gene Regulatory Elements Used in Adeno-Associated Viral Vectors. Front Neurol 2021;12:745159. [PMID: 34671313 DOI: 10.3389/fneur.2021.745159] [Reference Citation Analysis]
32 Deidda G, Pierucci M, Crunelli V, Di Giovanni G. 5-HT/GABA interaction in neurodevelopment and plasticity. Prog Brain Res 2021;259:287-317. [PMID: 33541680 DOI: 10.1016/bs.pbr.2021.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Lowe SA, Usowicz MM, Hodge JJL. Neuronal overexpression of Alzheimer's disease and Down's syndrome associated DYRK1A/minibrain gene alters motor decline, neurodegeneration and synaptic plasticity in Drosophila. Neurobiol Dis 2019;125:107-14. [PMID: 30703437 DOI: 10.1016/j.nbd.2019.01.017] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Raveau M, Polygalov D, Boehringer R, Amano K, Yamakawa K, McHugh TJ. Alterations of in vivo CA1 network activity in Dp(16)1Yey Down syndrome model mice. Elife 2018;7:e31543. [PMID: 29485402 DOI: 10.7554/eLife.31543] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
35 Barca-Mayo O, Boender AJ, Armirotti A, De Pietri Tonelli D. Deletion of astrocytic BMAL1 results in metabolic imbalance and shorter lifespan in mice. Glia 2020;68:1131-47. [PMID: 31833591 DOI: 10.1002/glia.23764] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
36 Alldred MJ, Chao HM, Lee SH, Beilin J, Powers BE, Petkova E, Strupp BJ, Ginsberg SD. Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. FASEB J 2019;33:9871-84. [PMID: 31180719 DOI: 10.1096/fj.201802669RR] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
37 Atas-Ozcan H, Brault V, Duchon A, Herault Y. Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome. Genes (Basel) 2021;12:1833. [PMID: 34828439 DOI: 10.3390/genes12111833] [Reference Citation Analysis]
38 Glass TJ, Valmadrid LCV, Connor NP. The Adult Ts65Dn Mouse Model of Down Syndrome Shows Altered Swallow Function. Front Neurosci 2019;13:906. [PMID: 31555077 DOI: 10.3389/fnins.2019.00906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
39 Thapliyal S, Vasudevan A, Dong Y, Bai J, Koushika SP, Babu K. The C-terminal of CASY-1/Calsyntenin regulates GABAergic synaptic transmission at the Caenorhabditis elegans neuromuscular junction. PLoS Genet 2018;14:e1007263. [PMID: 29529030 DOI: 10.1371/journal.pgen.1007263] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
40 Janoš P, Magistrato A. All-Atom Simulations Uncover the Molecular Terms of the NKCC1 Transport Mechanism. J Chem Inf Model 2021;61:3649-58. [PMID: 34213892 DOI: 10.1021/acs.jcim.1c00551] [Reference Citation Analysis]
41 Valbuena S, Lerma J. Losing balance: Kainate receptors and psychiatric disorders comorbidities. Neuropharmacology 2021;191:108558. [PMID: 33862031 DOI: 10.1016/j.neuropharm.2021.108558] [Reference Citation Analysis]
42 Panagaki T, Lozano-Montes L, Janickova L, Zuhra K, Szabo MP, Majtan T, Rainer G, Maréchal D, Herault Y, Szabo C. Overproduction of hydrogen sulfide, generated by cystathionine β-synthase, disrupts brain wave patterns and contributes to neurobehavioral dysfunction in a rat model of down syndrome. Redox Biol 2022;:102233. [PMID: 35042677 DOI: 10.1016/j.redox.2022.102233] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
43 Wasek B, Arning E, Bottiglieri T. The use of microwave irradiation for quantitative analysis of neurotransmitters in the mouse brain. Journal of Neuroscience Methods 2018;307:188-93. [DOI: 10.1016/j.jneumeth.2018.05.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
44 Kida E, Walus M, Albertini G, Golabek AA. Long-term voluntary running modifies the levels of proteins of the excitatory/inhibitory system and reduces reactive astrogliosis in the brain of Ts65Dn mouse model for Down syndrome. Brain Res 2021;1766:147535. [PMID: 34043998 DOI: 10.1016/j.brainres.2021.147535] [Reference Citation Analysis]
45 Parrini M, Naskar S, Alberti M, Colombi I, Morelli G, Rocchi A, Nanni M, Piccardi F, Charles S, Ronzitti G, Mingozzi F, Contestabile A, Cancedda L. Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndrome. Mol Ther 2021:S1525-0016(21)00305-1. [PMID: 34058387 DOI: 10.1016/j.ymthe.2021.05.023] [Reference Citation Analysis]
46 Lodovichi C, Ratto GM, Trevelyan AJ, Arosio D. Genetically encoded sensors for Chloride concentration. J Neurosci Methods 2021;:109455. [PMID: 34952088 DOI: 10.1016/j.jneumeth.2021.109455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
47 Qin L, Qiao C, Sheen V, Wang Y, Lu J. DNMT3L promotes neural differentiation by enhancing STAT1 and STAT3 phosphorylation independent of DNA methylation. Prog Neurobiol 2021;201:102028. [PMID: 33636226 DOI: 10.1016/j.pneurobio.2021.102028] [Reference Citation Analysis]
48 Golovko AI, Ivanov MB, Golovko ES, Dolgo-saburov VB, Zatsepin EP. The Neurochemical Mechanisms of the Pharmacological Activities of Inverse Agonists of the Benzodiazepine Binding Site. Neurochem J 2018;12:337-46. [DOI: 10.1134/s1819712418030042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Gómez de Salazar M, Grau C, Ciruela F, Altafaj X. Phosphoproteomic Alterations of Ionotropic Glutamate Receptors in the Hippocampus of the Ts65Dn Mouse Model of Down Syndrome. Front Mol Neurosci 2018;11:226. [PMID: 30140203 DOI: 10.3389/fnmol.2018.00226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
50 Consorti A, Di Marco I, Sansevero G. Physical Exercise Modulates Brain Physiology Through a Network of Long- and Short-Range Cellular Interactions. Front Mol Neurosci 2021;14:710303. [PMID: 34489641 DOI: 10.3389/fnmol.2021.710303] [Reference Citation Analysis]
51 Deidda G, Biazzo M. Gut and Brain: Investigating Physiological and Pathological Interactions Between Microbiota and Brain to Gain New Therapeutic Avenues for Brain Diseases. Front Neurosci 2021;15:753915. [PMID: 34712115 DOI: 10.3389/fnins.2021.753915] [Reference Citation Analysis]
52 Utagawa EC, Moreno DG, Schafernak KT, Arva NC, Malek-Ahmadi MH, Mufson EJ, Perez SE. Neurogenesis and neuronal differentiation in the postnatal frontal cortex in Down syndrome. Acta Neuropathol Commun 2022;10:86. [PMID: 35676735 DOI: 10.1186/s40478-022-01385-w] [Reference Citation Analysis]
53 Farrell C, Mumford P, Wiseman FK. Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches. Front Neurosci 2022;16:909669. [DOI: 10.3389/fnins.2022.909669] [Reference Citation Analysis]
54 Green MV, Raybuck JD, Zhang X, Wu MM, Thayer SA. Scaling Synapses in the Presence of HIV. Neurochem Res 2019;44:234-46. [PMID: 29541929 DOI: 10.1007/s11064-018-2502-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
55 Xu R, Brawner AT, Li S, Liu JJ, Kim H, Xue H, Pang ZP, Kim WY, Hart RP, Liu Y, Jiang P. OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome. Cell Stem Cell 2019;24:908-926.e8. [PMID: 31130512 DOI: 10.1016/j.stem.2019.04.014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 12.7] [Reference Citation Analysis]
56 Borgogno M, Savardi A, Manigrasso J, Turci A, Portioli C, Ottonello G, Bertozzi SM, Armirotti A, Contestabile A, Cancedda L, De Vivo M. Design, Synthesis, In Vitro and In Vivo Characterization of Selective NKCC1 Inhibitors for the Treatment of Core Symptoms in Down Syndrome. J Med Chem 2021;64:10203-29. [PMID: 34137257 DOI: 10.1021/acs.jmedchem.1c00603] [Reference Citation Analysis]
57 Abruzzo PM, Panisi C, Marini M. The Alteration of Chloride Homeostasis/GABAergic Signaling in Brain Disorders: Could Oxidative Stress Play a Role? Antioxidants (Basel) 2021;10:1316. [PMID: 34439564 DOI: 10.3390/antiox10081316] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Parrini M, Ghezzi D, Deidda G, Medrihan L, Castroflorio E, Alberti M, Baldelli P, Cancedda L, Contestabile A. Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome. Sci Rep 2017;7:16825. [PMID: 29203796 DOI: 10.1038/s41598-017-17201-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]